$BCLI

$1.05 -$0.02 (1.87%) Close

$BCLI Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 11.0M shares outstanding

Who owns BCLI?

By type of holder

Institutions 0.0% Insiders 29.6% Everyone else 70.4%

Concentration Top 10 holders own 29.4%

Lebovits Chaim 19.3% · Frenkel Jacob A 3.1%

Institutional ownership

0.0%

0.0 pts vs last qtr

Institutional holders

0 vs last qtr

Net shares bought

by institutions in Q2 2026

New / sold out

0 / 0

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

None.

Biggest sellers in Q2 2026

None.

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Brainstorm Cell Therapeutics Inc in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2020–FY2025

+363.5%

+35.90% a year

Each share's claim on the business

−78.4%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

$116K vs $9.32M

over 6 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

No 13F manager reports holding BCLI.

Super Investors

Investment managers reporting BCLI on Form 13F

No 13F manager reports holding BCLI yet.

Institutional Funds

Mutual funds and ETFs reporting BCLI on Form N-PORT; together they hold 1.2% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
VT Vanguard Total Stock Market Index Fund Vanguard Index Funds	$115K	50.7K	0.46%	0.00%	December 31, 2024
FE Fidelity Extended Market Index Fund Fidelity Concord Street Trust	$35.2K	31.4K	0.28%	0.00%	May 31, 2025

Vanguard Total Stock Market Index Fund

Vanguard Index Funds

Position value

$115K

% of company

0.46%

% of the fund

0.00%

As of

December 31, 2024

Fidelity Extended Market Index Fund

Fidelity Concord Street Trust

Position value

$35.2K

% of company

0.28%

% of the fund

0.00%

As of

May 31, 2025

5 more funds behind a free account

See every fund holding Brainstorm Cell Therapeutics Inc and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
LC Lebovits Chaim Insider	2.1M	19.34%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company19.340% Lebovits Chaim's insider activity →
FJ Frenkel Jacob A Insider	343.8K	3.12%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company3.120% Frenkel Jacob A's insider activity →

Lebovits Chaim

Insider

2.1M

% of company

19.34%

Change vs last qtr

—

Held since

—

Frenkel Jacob A

Insider

343.8K

% of company

3.12%

Change vs last qtr

—

Held since

—

9 more holders behind a free account

See every insider and 5%+ holder of Brainstorm Cell Therapeutics Inc.

Comments